Target intelligence / Profile preview

Basic transcription factor 3 pseudogene 14 (BTF3P14)

Target: BTF3P14
Molecular classification: Other (Pseudogene)

Overview

Basic transcription factor 3 pseudogene 14 (BTF3P14) is a noncoding genomic sequence classified as a pseudogene, meaning it is a DNA sequence that resembles the functional gene "basic transcription factor 3" (BTF3) but is not believed to be transcribed into a functional protein[1][4]. It has no known biological, regulatory, or disease-related function and is not considered a therapeutic target. Like other pseudogenes, BTF3P14 is thought to be a product of gene duplication or retrotransposition and is commonly annotated in genome reference databases for completeness rather than functional significance[1][4][7].

Other names: BTF3P14basic transcription factor 3 pseudogene 14

Beyond the preview

Go deeper on Basic transcription factor 3 pseudogene 14 (BTF3P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic transcription factor 3 pseudogene 14 (BTF3P14).

Explore the full profile